Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Authors
Keywords
-
Journal
Therapeutic Advances in Musculoskeletal Disease
Volume 8, Issue 6, Pages 225-235
Publisher
SAGE Publications
Online
2016-10-07
DOI
10.1177/1759720x16670154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cortical and trabecular load sharing in the human femoral neck
- (2015) Shashank Nawathe et al. JOURNAL OF BIOMECHANICS
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab
- (2015) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis and fragility fractures: Vertebral fractures
- (2014) Paul Gerdhem BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Inhibition of Cathepsin K Increases Modeling-Based Bone Formation, and Improves Cortical Dimension and Strength in Adult Ovariectomized Monkeys
- (2014) Brenda L Pennypacker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
- (2014) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
- (2013) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treat-to-target for Osteoporosis: Is Now the Time?
- (2013) E. Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Impact of Nonhip Nonvertebral Fractures in Elderly Women and Men
- (2013) Dana Bliuc et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Age- and Menopause-Related Bone Loss Compromise Cortical and Trabecular Microstructure
- (2013) E. Seeman JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice
- (2013) Nicolas Bonnet et al. PLoS One
- Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
- (2012) Richard M Jacques et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
- (2012) Bente Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo
- (2012) Anke J Roelofs et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene
- (2012) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial
- (2012) L. Yang et al. OSTEOPOROSIS INTERNATIONAL
- Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
- (2011) Paul J. Kostenuik et al. BONE
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
- (2011) Matthew Austin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys
- (2011) Patricia J Masarachia et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey
- (2011) Tara Cusick et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
- (2011) P. D. Miller et al. OSTEOPOROSIS INTERNATIONAL
- Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
- (2011) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis: burden, health care provision and opportunities in the EU
- (2011) O. Ström et al. Archives of Osteoporosis
- Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate
- (2010) Paul D. Miller et al. CALCIFIED TISSUE INTERNATIONAL
- Bone resorption and formation on the periosteal envelope of the ilium: A histomorphometric study in healthy women
- (2010) Raffaella Balena et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study
- (2010) Roger MD Zebaze et al. LANCET
- Tibia Adaptation after Fibula Harvesting: An in Vivo Quantitative Study
- (2009) Fulvia Taddei et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo
- (2009) Anke J Roelofs et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
- (2008) Fraser P. Coxon et al. BONE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search